Da Li

机构：Qingdao University, Sir Run Run Shaw Hospital, Jilin Academy of Agricultural Sciences, Affiliated Hospital of Qingdao University, China Medical University · ORCID：0000-0002-9918-9135

发表论文 167 篇 · 总被引 1900 次 · h-index 27

代表论文

• Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma (2024 · Hepatology International · 被引 15)
• Hepatic arterial chemotherapy infusion combined with tyrosine kinase inhibitors and PD-1 inhibitors for advanced hepatocellular carcinoma with high risk: a propensity score matching study (2024 · International Journal of Surgery · 被引 14)
• Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial (2025 · Nature Communications · 被引 12)
• Peroxisome proliferator-activated receptor gamma agonist pioglitazone alleviates hemorrhage-induced thalamic pain and neuroinflammation (2023 · International Immunopharmacology · 被引 10)
• A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients (2023 · BMC Pulmonary Medicine · 被引 8)
• Transcription activation of SPINK4 by ELF-1 augments progression of colon cancer by regulating biological behaviors (2023 · Tissue and Cell · 被引 4)